NCT-504

目录号: PL09198 纯度: ≥98%
NCT-504 是选择性的脂质激酶 PIP4Kγ 变构抑制剂,其 IC50 值为 15.8 μM。NCT-504 具有用于亨廷顿氏症疾病研究的潜力。
CAS No. :1222765-97-0
商品编号 规格 价格 会员价 是否有货 数量
PL09198-5mg 5mg ¥5143.00 请登录
PL09198-10mg 10mg ¥8197.00 请登录
PL09198-25mg 25mg ¥16876.00 请登录
PL09198-50mg 50mg 询价 询价
PL09198-100mg 100mg 询价 询价
PL09198-10mM*1mLinDMSO 10mM*1mLinDMSO ¥5657.00 请登录
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
*注意事项:下单时请联系销售核实产品价格及货期,避免后续产生不便,感谢支持!
中文名称
NCT-504
英文名称
NCT-504
英文别名
5-(3-methylsulfonylphenyl)-4-[(1-methyl-5-tetrazolyl)thio]thieno[2,3-d]pyrimidine;MLS002264468;HMS2210A07;HMS3341J07;BDBM50511426;SMR001317769;Q27164880;NCT-504
Cas No.
1222765-97-0
分子式
C15H12N6O2S3
分子量
404.49
包装储存
Powder -20°C 3 years;In solvent -80°C 6 months
详情描述
NCT-504 是选择性的脂质激酶 PIP4Kγ 变构抑制剂,其 IC50 值为 15.8 μM。NCT-504 具有用于亨廷顿氏症疾病研究的潜力。
产品详情
NCT-504 是选择性的脂质激酶 PIP4Kγ 变构抑制剂,其 IC50 值为 15.8 μM。NCT-504 具有用于亨廷顿氏症疾病研究的潜力。
生物活性
NCT-504 is a selective allosteric inhibitor of PIP4Kγ, with an IC 50 of 15.8 μM. NCT-504 is potential for the research of Huntingtons disease.
性状
Solid
IC50 & Target[1][2]
IC50: 15.8 μM (PIP4Kγ)
体外研究(In Vitro)
NCT-504 dose not impair the intrinsic ATP-hydrolytic activity of PIP4Kγ in the absence of PI5P substrate.
NCT-504 does not inhibit PIP4Kbeta and weakly inhibits PIP4Kalpha phosphorylation of PI5P .
NCT-504 dose not inhibit PIP4Kbeta or PIP4Kalpha (IC50 between 50 μM and 100 μM) at 50 μM concentration.
NCT-504 elevates the levels of PI(3,5)P2, PI3P and PI5P in MEFs.
NCT-504 (10 μM; 12 hours) does not affect cell viability in MEFs.
NCT-504 (5 μM, 10 μM; 2 hours, 6 hours) elevates both the induction of autophagy as well as the rate of turnover of autophagic cargo.
NCT-504 treatment causes a robust increase in the formation of autolysosomes with only a modest elevation in autophagosomes.
NCT-504 increases autophagy flux and decreases huntingtin protein in 293A cells.
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years;In solvent -80°C 6 months
参考文献
[1]. Ismael Al-Ramahi, et al. Inhibition of PIP4Kγ Ameliorates the Pathological Effects of Mutant Huntingtin Protein. Elife. 2017 Dec 26;6:e29123.
溶解度数据
In Vitro: DMSO : 125 mg/mL (309.03 mM; Need ultrasonic)配制储备液
搜索质检报告(COA)
[1]. Ismael Al-Ramahi, et al. Inhibition of PIP4Kγ Ameliorates the Pathological Effects of Mutant Huntingtin Protein. Elife. 2017 Dec 26;6:e29123.

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2